GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care

GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care

Type 2 diabetes mellitus (T2DM) is a multifactorial disease characterized by insulin resistance, beta-cell dysfunction, and chronic hyperglycemia. Despite the availability of conventional therapies, significant unmet needs persist in achieving optimal glycemic control and reducing long-term complic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Agnieszka Parfianowicz, Alicja Surma
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2025-02-01
Series:	Journal of Education, Health and Sport
Subjects:	type 2 diabetes flozyns dm 2
Online Access:	https://apcz.umk.pl/JEHS/article/view/57478
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Comparison and Correlation of Serum Levels of Insulin and Na+/ K+ Atpase In Type 2 Diabetes Mellitus (T2DM) And Non-Diabetes Mellitus Individuals
by: Karar Kazem Mohammed, et al.
Published: (2022-09-01)

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
by: Xu He, et al.
Published: (2025-01-01)

Association of age at menopause with type 2 diabetes mellitus in postmenopausal women: a systematic review and meta-analysis
by: Faezeh Zakerinasab, et al.
Published: (2024-12-01)

Epidemiology of Pulmonary Tuberculosis in Diabetes Mellitus Patients
by: Siti Ananda Hardita Syahputri, et al.
Published: (2023-10-01)

Region-specific hippocampal atrophy is correlated with poor glycemic control in type 2 diabetes: a cross-sectional study
by: Cuiping Bao, et al.
Published: (2023-12-01)

Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
by: Xiaoyu Chen, et al.
Published: (2023-11-01)

BDNF Levels and Cognitive Function in Patients with Type 2 Diabetes Treated with SGLT2 Inhibitors
by: Betül SÜMBÜL ŞEKERCİ, et al.
Published: (2025-01-01)

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01)

The Effect of Combination Foot Massage and Active Range of Motion (ROM) on Foot Sensitivity among Patients with Type 2 Diabetic Mellitus
by: I Made Cahyadi Agastiya, et al.
Published: (2025-01-01)

RETRACTED ARTICLE: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes
by: Jianbin Guan, et al.
Published: (2024-06-01)

An association study of polymorphisms in the P2RX7 gene in an Iranian population with the risk of type 2 diabetes mellitus
by: Homa Noori, et al.
Published: (2025-01-01)

The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required
by: Alan J. Sinclair, et al.
Published: (2025-01-01)

Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis
by: Xiaoyan Liang, et al.
Published: (2025-01-01)

Apoptosis in the liver of male <em>db/db</em> mice during the development of obesity and type 2 diabetes
by: S. V. Michurina, et al.
Published: (2020-07-01)

The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus
by: Rujie Zheng, et al.
Published: (2025-02-01)

Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus
by: Haoyi Yang, et al.
Published: (2025-01-01)

Blood metabolomic profile in patients with type 2 diabetes mellitus with diabetic peripheral neuropathic pain
by: Hung‐Chou Kuo, et al.
Published: (2025-02-01)

Leptin levels in obese women with and without type 2 diabetes mellitus
by: Mehmet Akif Buyukbese, et al.
Published: (2004-01-01)

Effect of Educational Intervention Program on Self-Efficacy of Individuals with Type 2 Diabetes Mellitus in South-East, Nigeria.
by: Okafor, Christiana Nkiru, et al.
Published: (2024)

Self-Care Practices and the Associated Socio-Demographic Variables of Persons With Type 2 Diabetes Mellitus (T2dm) in Southeast, Nigeria.
by: Okafor, Christiana Nkiru, et al.
Published: (2024)

Self-Care Practices and the Associated Socio-Demographic Variables of Persons with Type 2 Diabetes Mellitus (T2dm) in Southeast, Nigeria.
by: Okafor, Christiana Nkiru, et al.
Published: (2024)

Exploring Inflammatory Changes in the Peripheral Blood of Type 2 Diabetes Mellitus in China
by: Li D, et al.
Published: (2025-02-01)

Awareness About Diabetes And Its Complications Among Patients With Diabetes Mellitus
by: Faiza Batool, et al.
Published: (2023-12-01)

Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
by: Jelena Petković-Dabić, et al.
Published: (2025-01-01)

Association between previous consumption of sugar-sweetened beverages and diabetes remission in patients with newly diagnosed type 2 diabetic ketoacidosis
by: Shanshan Li, et al.
Published: (2024-09-01)

Reduction of Hepatic Fat Content by Dulaglutide for the Treatment of Diabetes Mellitus: A Two‐Centre Open, Single‐Arm Trial
by: Chuanfeng Liu, et al.
Published: (2025-01-01)

Abnormal insulin metabolism and decreased levels of mindfulness in type 2 diabetes mellitus
by: Xue Zhang, et al.
Published: (2025-01-01)

Recent advances in the managements of type 2 diabetes mellitus and natural hypoglycemic substances
by: Chong Ning, et al.
Published: (2022-09-01)

Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus
by: Soumitra Ray, et al.
Published: (2024-04-01)

Cortical Gyrification and Cognitive Decline in the Human Brain With Type 2 Diabetes Mellitus
by: Weiye Lu, et al.
Published: (2025-01-01)

Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
by: Alaa Abed Mahmoud, et al.
Published: (2023-06-01)

The incremental value of aspartate aminotransferase/alanine aminotransferase ratio combined with CURB-65 in predicting treatment outcomes in hospitalized adult community-acquired pneumonia patients with type 2 diabetes mellitus
by: Huamei Zhou, et al.
Published: (2025-01-01)

A retrospective study of 5S behaviours of Physical Activity (PA) among suburban Mumbai population with Type 2 Diabetes Mellitus (T2DM)
by: Kosha Parikh, et al.
Published: (2025-01-01)

Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
by: Fangyu Li, et al.
Published: (2025-01-01)

Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus
by: Motahare Shabestari, et al.
Published: (2025-02-01)

Association Between Prebiotic or Probiotic Consumption and Risk of Type 2 Diabetes Mellitus in the General Adult Population
by: Şefika Tuğba Yangöz, et al.
Published: (2024-08-01)

Association of homocysteine and uric acid with type 2 diabetes mellitus: a case-control study
by: Xiaolong Yang, et al.
Published: (2025-01-01)

A nomogram for predicting bladder dysfunction in patients with type 2 diabetes mellitus: a retrospective study
by: Yingjie Hu, et al.
Published: (2025-01-01)

Vitamin D Deficiency in Patients with Type 2 Diabetes Mellitus with and without Pulmonary Tuberculosis
by: Wahiduddin Wahiduddin, et al.
Published: (2024-11-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)